Year: 2025

NEW YORK, NY, Oct. 31, 2025 (GLOBE NEWSWIRE) — 1847 Holdings LLC (“1847” or the “Company”) (OTCID: LBRA), a holding company specializing in identifying overlooked, deep-value investment opportunities in middle market businesses, today announced a significant favorable development in a pending civil lawsuit, Case No. #1:25-cv-08606-LAK, filed in the United States District Court for the Southern District of New York by Plaintiff Matthew Miller. On October 28, 2025, the Court entered an Order [D.E. 35], sua sponte, dismissing Plaintiff’s First Amended Complaint [D.E. 34], without prejudice to Plaintiff filing an amended complaint, no more than 40 pages long, on or before November 24, 2025. The First Amended Complaint, which had been filed four days before the Court’s issuance of its dismissal Order, alleged...

TEL AVIV, Israel, Oct. 31, 2025 (GLOBE NEWSWIRE) —  Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva’s President and CEO, will present at two upcoming investor conferences in November as follows:UBS Global Healthcare ConferenceMonday, November 10, 2025, at 8:45 A.M. Eastern Time (ET)Jefferies London Healthcare ConferenceTuesday, November 18, 2025, at 11:00 A.M. Greenwich Mean Time (6:00 A.M. ET)To access a live webcast of the presentation, visit Teva’s Investor Relations website at https://ir.tevapharm.com/Events-and-Presentations. An archived version of the webcast will be available within 24 hours after the end of the live discussion. About Teva Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) is a leading innovative biopharmaceutical company, enabled by...

BOSTON, Oct. 31, 2025 (GLOBE NEWSWIRE) — Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that, on October 15, 2025, the Compensation Committee of the Board of Directors granted stock options to purchase an aggregate of 113,478 shares of Vor Bio’s common stock and restricted stock units (“RSUs”) representing the right to receive an aggregate of 24,319 shares of Vor Bio’s common stock to 20 newly hired employees. The foregoing stock options and RSUs were granted as material inducements to employment with Vor Bio in accordance with Nasdaq Listing Rule 5635(c)(4) and were granted under the Vor Biopharma Inc. 2023 Inducement Plan (the “Inducement Plan”).         The stock options have a ten-year term, and the exercise price is $30.22 per share, which is...

Hong Kong, Oct. 31, 2025 (GLOBE NEWSWIRE) — Global Engine Group Holding Limited (the “Company”), a Hong Kong-headquartered integrated solutions provider in information communication technologies (“ICT”), today announced that it has received a notice (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”), dated October 27, 2025, stating that the Company is not in compliance with the requirement to maintain a minimum bid price of $1 per share as set forth under Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Rule”) for continued listing on The Nasdaq Capital Market. Nasdaq Listing Rule 5810(c)(3)(A) provides that a failure to meet the minimum bid price requirement exists if the deficiency continues for a period of 30 consecutive business days. Based upon the closing bid price of the Company’s Class A ordinary shares (the...

CHARLOTTE, N.C., Oct. 31, 2025 (GLOBE NEWSWIRE) — NN, Inc. (NASDAQ: NNBR), a global diversified industrial company that engineers and manufactures high-precision components and assemblies, announced today that Harold Bevis, President and Chief Executive Officer will be presenting at the Gabelli Funds 49th Annual Automotive Symposium on November 3, 2025 in Las Vegas. The presentation will begin at 4:30 p.m. PT (7:30 p.m. ET) on Monday, November 3, 2024. Investors interested in accessing the Company’s presentation may register to access the live event here. All registrants will receive a link to the event upon registration. A link to the presentation and associated materials can also be accessed through the investor section of the Company’s website at www.nninc.com. About NN, Inc.NN, Inc., a global diversified industrial company,...

Lima, Oct. 31, 2025 (GLOBE NEWSWIRE) — Lima, PERU, October 31st, 2025 – Credicorp Ltd. announces to its shareholders and the market that its 3Q25 Earnings Release will be published on Thursday, November 13th, 2025, after market close. Credicorp’s webcast and conference call to discuss these results will be held on Friday, November 14th, 2025, at 9:30 a.m. Lima, Peru time and 9:30 a.m. Eastern Time. The call will be hosted by the following Credicorp executivesGianfranco Ferrari, Chief Executive Officer Alejandro Perez Reyes, Chief Financial Officer Francesca Raffo, Chief Innovation Officer Cesar Rios, Chief Risk Officer Cesar Rivera, Head of Insurance and Pensions Rocio Benavides, Mibanco CFO Investor Relations TeamParticipants are encouraged to pre-register for the listen-only webcast at the following link:https://dpregister.com/DiamondPassRegistration/register?confirmationNumber=10204236&linkSecurityString=10040c5080c Callers...

PHILADELPHIA and NEW YORK, Oct. 31, 2025 (GLOBE NEWSWIRE) — Cohen & Company Inc. (NYSE American: COHN) will release its financial results for the third quarter 2025 on Tuesday, November 4, 2025. The Company will host a conference call at 10:00 a.m. Eastern Time (ET) that day to discuss these results. The conference call will be available via webcast. Interested parties can access the webcast by clicking the webcast link on the Company’s homepage at www.cohenandcompany.com. Those wishing to listen to the conference call with operator assistance can dial (877) 524-8416 (domestic) or +1 (412) 902-1028 (international). A replay of the call will be available for three days following the call by dialing (877) 660-6853 or (201) 612-7415, with participant passcode 13756943. About Cohen & Company Cohen & Company is a financial...

AUSTIN, Texas, Oct. 31, 2025 (GLOBE NEWSWIRE) — Astrotech Corporation (Nasdaq: ASTC) (the “Company” or (“Astrotech”), today announced that it has appointed Scott Bartley as Interim Chief Financial Officer (“CFO”) of the Company, effective as of October 20, 2025. “We are pleased to announce Scott Bartley as Chief Financial Officer,” stated Thomas B. Pickens III, Chairman and Chief Executive Officer of Astrotech Corporation. “He brings over two decades of expertise as a Controller and CFO, across multiple industries, providing important qualification and vantage points for our business across multiple end markets.”​Mr. Bartley, age 56, has served as a financial consultant since 2011, including roles as Chief Financial Officer and controller for both public and private companies where he provided detailed accounting, reporting, fundraising...